Jie Min Wang

Dr. Jie Min Wang


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2025 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
DYDandan Yang
Dandan Yang
NANamila
Namila
HAHashentuya
Hashentuya
TATana
Tana
WUWuyunsiqin
Wuyunsiqin
JWJie Min Wang
Jie Min Wang

21 March 2025 in Medicine
Verified
Journal Article
Open access
QGQian Gao
Qian Gao
YCYan Cui
Yan Cui
FGFeng Gao
Feng Gao
YYYan Yang
Yan Yang
WHWeizhong Huangfu
Weizhong Huangfu
JWJie Min Wang
Jie Min Wang
PDGFRB is a type III tyrosine-protein kinase that is abnormally expressed in various cancers and can serve as a biomarker for cancer prognosis, as studies have demonstrated. However, a pan-cancer analysis of PDGFRB has not yet been carried out. The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases were utilized to analyze PDGFRB expression levels. Differential expression of PDGFRB in standard, tumor, and different clinical stage samples was calculated using R software (version 3.6.4). Immunohistochemical staining for Cholangiocarcinoma (CHOL) and Esophageal carcinoma (ESCA) was conducted on clinical patient samples. High-quality prognostic datasets from TCGA have been published in previous studies. Additionally, the TARGET follow-up data were obtained as supplementary information, excluding models with a follow-up period of less than 30 days. After conducting a rain analysis of PDGFRB, Kaplan–Meier and univariate Cox regression analyses were performed using the R software package. The DNA tumor stemness scores, derived from methylation signatures for each tumor, were obtained from previous studies. Finally, the infiltration of immune cells was analyzed, and the Pearson correlation between PDGFRB and five immune pathway marker genes was assessed. PDGFRB exhibited differential expression across most tumor types in TCGA, indicating a correlation with poor survival outcomes. The expression of PDGFRB influences the regulation of the immune system and is closely associated with immune cell infiltration, immune checkpoints, immune-activating genes, immune suppressor genes, chemokines, and chemokine receptors. PDGFRB is a cancer gene closely associated with prognosis and immunity in cancer patients, and it may serve as an immune checkpoint.

20 March 2026 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
FBFushun Bao
Fushun Bao
NWNing Wang
Ning Wang
QGQi Guo
Qi Guo
JLJun Li
Jun Li
WZWenxue Zhang
Wenxue Zhang
JWJie Min Wang
Jie Min Wang

20 June 2026 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
NWNing Wang
Ning Wang
WZWenxue Zhang
Wenxue Zhang
JLJun Li
Jun Li
FBFushun Bao
Fushun Bao
WFWeihua Feng
Weihua Feng
JWJie Min Wang
Jie Min Wang